About
This panel discussion took place at BioData World Congress in Basel, Switzerland on 09 November.

Data integration and AI/ML are seemingly everywhere and are increasingly recognized as critical to accelerating the advancement of precision medicine.

Healthcare institutions and BioPharma companies aim to make more informed decisions by combining a diversity of data modalities with the longitudinal follow-up of patients from diagnosis to treatment and outcomes, with the goal of better understanding the patient journey and identifying optimal subpopulations for care.

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
on-demand webinar
Agenda
  • The essential questions addressed in this on-demand webinar include the following:
  • 1) How can this approach be applied on a large scale?
  • 2) Who will benefit from these technologies?
  • 3) How can we move from R&D to clinical practice today and in the future?
  • 4) How will these algorithmic approaches impact or guide decision-making?
  • 5) Do we promise the impossible, or is there hope for validated, multimodal data analysis?
Presenters
1669715511-fdc1c12f4fe99efd
Peter Casasanto, MS, MBA
Chief BioPharma Officer, SOPHiA GENETICS
1669716007-7f038d502df24434
David Dellamonica, MBA
Head, Digital and Innovation, Oncology, Europe & Canada, AstraZeneca
1669715680-780296a105da09e3
Michael G. Frank, MBA
Digital Ventures Lead, Memorial Sloan Kettering Cancer Center (MSKCC)
1669716412-3b42b4e23243eec0
Prof. Jacques Cadranel, MD
Oncologist, Pneumology Service, Assistance Publique – Hôpitaux de Paris, France
1669714748-9ce4bbd3fcd21a77
Philippe Menu, MD, PhD, MBA
Chief Medical Officer, SOPHiA GENETICS
Register To Watch Recording
Full name*
Email Address*
Company (required)*
Job Title (required)*
City (required)*
Country (required)*
✓
✓
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker